Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07367880

The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Alzheimer s Disease

Age range

50 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Grenoble Alpes

Grenoble, France

Location status: Recruiting

Location contact

Aurélie TRUFFOT

CONTACT

[email protected]

0786498337

Aurélie TRUFFOT

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Alzheimer's disease:
  • Age ≥ 50 years and older
  • Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
  • Score 18≤ MMSE ≤26
  • Controls:
  • Age ≥ 50 years and older
  • MMSE score ≥ 26 For all subjects
  • No objection from the participant

Exclusion criteria

  • Alzheimer's disease:
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP
  • Controls:
  • Memory complaints
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
  • Significant neurological or psychiatric history
  • Taking psychotropic medication (neuroleptics)
  • Poor command of the French language, comprehension difficulties
  • Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
  • Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Treatment and study plan

Identification and naming task

Other

Task of identification and naming of landmarks and celebrities

Primary outcomes

  1. Difference between the two groups in the identification and naming task involving famous landmarks

    Time frame: 1 month

    show a significant difference in performance between the two groups in the identification and naming task involving famous landmarks

Secondary outcomes

  1. Development and standardization of a new tool for screening for naming disorders and visual identification of unique entities.

    Time frame: 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

Sabrina Iannuzzi, Neuropsychologist

CONTACT

[email protected]

+334.76.76.57.90

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Acronym: TeDIMO

Important dates

Study start
2026
Primary completion
2031
Study completion
2032
First posted
Jan 26, 2026
Registry last updated
May 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.